No connection

Search Results

AFJKR

BEARISH
$0.39 Live
Aimei Health Technology Co., Ltd · NASDAQ
$0.3 52W Range $0.39

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
92%
AFJKR exhibits severe financial distress, as evidenced by a Piotroski F-Score of 3/9, indicating weak operational and financial health. The absence of an Altman Z-Score and a negative ROA of -1.04% further signal deteriorating fundamentals. With a current price of $0.39 trading at a negative Price/Book ratio of -0.69 and no profitability, the company shows no intrinsic value. Earnings have declined by 30.2% YoY and 52.7% Q/Q, while liquidity ratios are critically low (Current Ratio: 0.01, Quick Ratio: 0.00), suggesting imminent solvency concerns. The lack of analyst coverage and dividend yield reinforces the absence of investor confidence.

Key Strengths

Trading near its 52-week low of $0.30, offering potential downside protection
Low market cap may appeal to speculative investors seeking high-risk, high-reward opportunities
Price remains stable over multiple timeframes, indicating lack of significant selling pressure
No reported debt or equity data may suggest minimal leverage, though this is likely due to insolvency
Insider sentiment at 40/100 suggests neutral to slightly cautious positioning

Key Risks

Piotroski F-Score of 3/9 indicates poor financial health and weak operational performance
Negative Price/Book ratio (-0.69) implies market capitalization is below net asset value, a sign of distress
Current and quick ratios near zero indicate extreme liquidity risk and inability to meet short-term obligations
Negative ROA (-1.04%) and zero margins confirm ongoing unprofitability
No analyst coverage or target price suggests lack of institutional interest and limited visibility

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
14
Weak
Value
15
Future
10
Past
25
Health
18
Dividend
0
AI Verdict
High Risk
Key drivers: Low Piotroski F-Score (3/9), Negative ROA and margins, Extreme liquidity constraints, No profitability or growth, Absence of valuation metrics
Confidence
90%
Value
15/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • Negative Price/Book ratio indicates asset value is below market cap
  • No Graham Number or intrinsic value available
  • No P/E, PEG, or Price/Sales metrics for valuation
Future
10/100

Ref Growth rates

Positives
No standout positives identified.
Watchpoints
  • Earnings growth down 30.2% YoY and 52.7% Q/Q
  • No revenue growth data, but negative earnings trends suggest declining operations
  • No forward guidance or analyst estimates
Past
25/100

Ref Historical trends

Positives
  • Price has remained stable over 1-year, 6-month, and 1-week periods
  • Trading near 52-week low may indicate market pricing in downside
Watchpoints
  • No historical growth or profitability trends available
  • Zero margins and negative ROA suggest long-term deterioration
Health
18/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • No reported debt (though likely due to insolvency)
  • Low market cap may reduce systemic risk
Watchpoints
  • Piotroski F-Score of 3/9 indicates weak financial health
  • Current ratio of 0.01 and quick ratio of 0.00 signal severe liquidity risk
  • No Altman Z-Score available, but negative ROA and zero margins suggest distress
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend yield and payout ratio are not available
  • Dividend strength is 0/100, indicating no dividend payments

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.39

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AFJKR and closest competitors.

Updated 2026-03-13
AFJ
Aimei Health Technology Co., Ltd
Primary
5Y
0.0%
3Y
0.0%
1Y
0.0%
6M
0.0%
1M
0.0%
1W
0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
-0.69
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA -1.04%

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth -30.2%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -52.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
0.01
Weak
Quick Ratio
0.0
Poor
Cash/Share
$N/A

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Wolverine Asset Management, LLC
312,643 shares • 2025-12-31
Highbridge Capital Management, LLC.
900,000 shares • 2025-12-31
Harraden Circle Investments, LLC
1,089,365 shares • 2025-12-31
Clear Street Group Inc.
390,777 shares • 2025-12-31
Westchester Capital Management, LLC
288,212 shares • 2025-12-31
Toronto Dominion Bank
891,729 shares • 2025-12-31
RiverNorth Capital Management, LLC
172,789 shares • 2025-12-31
Shaolin Capital Management LLC
150,000 shares • 2025-12-31

Past News Coverage

Recent headlines mentioning AFJKR from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile